SHELINDA DENNIS: Open Payments
NPI 1396265385 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$199 in 8 payments from 4 companies in 2025. Trend: 2023 $71 · 2024 $124 · 2025 $199
Food & beverage: $199
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $104 |
| Teva Pharmaceuticals USA, Inc. | 1 | $38 |
| Otsuka America Pharmaceutical, Inc. | 1 | $34 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
Products named: VRAYLAR, AUSTEDO XR, REXULTI, HETLIOZ.
Industry payments across NV — which companies pay providers there.
